 IRVINE, CA ACCESSWIRE November 19, 2019 Hancock Jaffe Laboratories, Inc. NASDAQ:HJLI, HJLIW, a developer of medical devices that restore cardiac and vascular health, announced today that Dr. Jorge Hernando Ulloa, the Principal Investigator for HJLIs VenoValve study in Colombia, and Dr. Marc H. Glickman, HJLIs Senior Vice President and Chief Medical Officer, will be making presentations at the world renowned VEITH Vascular Symposium taking place November 19 to November 23 at the New York Hilton in New York City. Dr. Ulloa will be making two presentations on the VenoValve. 